Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study

Leonora S. F. Boogerd, Charlotte E. S. Hoogstins, Dennis P. Schaap, Miranda Kusters, Henricus J. M. Handgraaf, Maxime J. M. van der Valk, Denise E. Hilling, Fabian A. Holman, Koen C. M. J. Peeters, J. Sven D. Mieog, Cornelis J. H. van de Velde, Arantza Farina-Sarasqueta, Ineke van Lijnschoten, Berenice Framery, Andre Pelegrin, Marian Gutowski, Simon W. Nienhuijs, Ignace H. J. T. de Hingh, Grard A. P. Nieuwenhuijzen, Harm J. T. RuttenFrancoise Cailler, Jacobus Burggraaf, Alexander L. Vahrmeijer*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)181-191
Number of pages11
JournalThe Lancet Gastroenterology and Hepatology
Volume3
Issue number3
DOIs
Publication statusPublished - 1 Mar 2018

Keywords

  • RECTAL-CANCER
  • CYTOREDUCTIVE SURGERY
  • MACROMOLECULAR THERAPEUTICS
  • PERITONEAL CARCINOMATOSIS
  • CHEMOTHERAPY
  • CEA
  • METASTASES
  • PREDICTION
  • MARGIN

Cite this